title: [Scrofuloderma with hypersensitivity to rifampicin and pyrazinamide, treated with a combination therapy including ofloxacin].
authors: Ikram
authors: I
authors: Belghith
authors: Talel
authors: T
authors: Badri
authors: Ahmed
authors: A
authors: Zaiem
authors: Rym
authors: R
authors: Benmously
authors: Inçaf
authors: I
authors: Mokhtar
mesh_terms: D000328:Adult; D000904:Antibiotics, Antitubercular / Q000008:administration & dosage*; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007538:Isoniazid / Q000008:administration & dosage*; D015242:Ofloxacin / Q000008:administration & dosage*; D011718:Pyrazinamide / Q000008:administration & dosage* / Q000009:adverse effects*; D012293:Rifampin / Q000008:administration & dosage* / Q000009:adverse effects*; D013307:Streptomycin / Q000008:administration & dosage*; D014382:Tuberculosis, Cutaneous / Q000188:drug therapy*
chemical_list: D000904:Antibiotics, Antitubercular; D011718:Pyrazinamide; D015242:Ofloxacin; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin